SAMIR ABDALLAH HANNA

(Fonte: Lattes)
Índice h a partir de 2011
1
Projetos de Pesquisa
Unidades Organizacionais
LIM/02 - Laboratório de Anatomia Médico-Cirúrgica, Hospital das Clínicas, Faculdade de Medicina

Resultados de Busca

Agora exibindo 1 - 3 de 3
  • bookPart
    Tratamento do tumor de mama localizado
    (2013) BARROS, Alfredo Carlos S. D; KATZ, Artur; JARDIM, Denis Leonardo Fontes; BASTOS, Diogo Assed; MARTELLA, Eduardo; MARTA, Gustavo Nader; PEIXOTO, Renata D'Alpino; HANNA, Samir Abdallah
  • conferenceObject
    Ultra-hypofractionated Radiotherapy for Breast Cancer: A Brazilian Single-Institutional Series
    (2023) BRITO, Leticia Hernandes De; RESTINI, Felipe Cicci Farinha; STARLING, Maria Thereza Mansur; SIQUEIRA, Gabriela Silva Moreira De; MARTA, Gustavo Nader; CARVALHO, Heloisa De Andrade; HANNA, Samir Abdallah
  • article 10 Citação(ões) na Scopus
    Câncer de mama estádio inicial e radioterapia: atualização
    (2011) MARTA, Gustavo Nader; HANNA, Samir Abdallah; MARTELLA, Eduardo; SILVA, Joao Luis Fernandes da; CARVALHO, Heloisa de Andrade
    Early stage breast cancer and radiotherapy: update Breast cancer (BC) is the most common malignancy among women. Therapeutic options are based on disease staging, histopathological characteristics, age, and others. The objective of the present study is to carry out an update of the concepts and definitions of radiotherapy (RT) in conservative treatment of early-stage breast cancer, with emphasis on indications, contraindications, RT dose fractionation schedules (classic, hypofractionated and partial breast irradiation), adjuvant RT in ductal carcinoma in situ (DCIS) and molecular predictors of recurrence. MEDLINE, SciELO and Cochrane databases were used for article selection. Adjuvant RI is indicated for patients with BC who underwent conservative breast surgery. In selected patients, hypofractionated or partial breast irradiation can be used. Adjuvant RT should be provided for all patients with DCIS. The correlation of RT and molecular predictors of local and systemic recurrence are not yet well-known.